Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies

di Roy, R, Zurakowski, D, Wischhusen, J, Frauenhoffer, C, Hooshmand, S, Kulke, M, Moses, M A
Pubblicato in Br J Cancer (2014)

Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1)

di Diessner, J, Bruttel, V, Stein, R G, Horn, E, Häusler, S F M, Dietl, J, Hönig, A, Wischhusen, J
Pubblicazione 2014

Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening

di Häusler, S F M, Keller, A, Chandran, P A, Ziegler, K, Zipp, K, Heuer, S, Krockenberger, M, Engel, J B, Hönig, A, Scheffler, M, Dietl, J, Wischhusen, J
Pubblicazione 2010

CD74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survival

di Zeiner, P. S., Zinke, J., Kowalewski, D. J., Bernatz, S., Tichy, J., Ronellenfitsch, M. W., Thorsen, F., Berger, A., Forster, M. T., Muller, A., Steinbach, J. P., Beschorner, R., Wischhusen, J., Kvasnicka, H. M., Plate, K. H., Stefanović, S., Weide, B., Mittelbronn, M., Harter, P. N.
Pubblicato in Acta Neuropathol Commun (2018)